Technical Analysis for ABVX - ABIVAX Société Anonyme
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 14.14 | -0.98% | -0.14 |
ABVX closed down 1.92 percent on Wednesday, May 8, 2024, on 87 percent of normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
Earnings due: May 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | -0.98% | |
| New Downtrend | Bearish | -0.98% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | -0.98% | |
| Hammer Candlestick | Bullish | -0.98% | |
| Lower Bollinger Band Touch | Weakness | -0.98% | |
| Fell Below 50 DMA | Bearish | -2.88% | |
| 180 Bearish Setup | Bearish Swing Setup | -2.88% | |
| Stochastic Reached Oversold | Weakness | -2.88% | |
| Outside Day | Range Expansion | -2.88% | |
| Oversold Stochastic | Weakness | -2.88% |
| Alert | Time |
|---|---|
| Up 1% | 38 minutes ago |
| Down 1% | 44 minutes ago |
| Down 5% | about 20 hours ago |
| Down 1 ATR | about 20 hours ago |
| Down 3% | about 20 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2024
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Gastroenterology Ulcerative Colitis Colitis Diarrhea
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Autoimmune Disease Inflammatory Bowel Disease Gastroenterology Ulcerative Colitis Colitis Diarrhea
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.02 |
| 52 Week Low | 7.995 |
| Average Volume | 65,985 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 14.67 |
| 20-Day Moving Average | 15.13 |
| 10-Day Moving Average | 15.03 |
| Average True Range | 0.84 |
| RSI (14) | 41.18 |
| ADX | 27.6 |
| +DI | 16.83 |
| -DI | 24.67 |
| Chandelier Exit (Long, 3 ATRs) | 14.11 |
| Chandelier Exit (Short, 3 ATRs) | 15.90 |
| Upper Bollinger Bands | 16.06 |
| Lower Bollinger Band | 14.19 |
| Percent B (%b) | 0.05 |
| BandWidth | 12.32 |
| MACD Line | 0.01 |
| MACD Signal Line | 0.18 |
| MACD Histogram | -0.1701 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.34 | ||||
| Resistance 3 (R3) | 16.26 | 15.51 | 15.99 | ||
| Resistance 2 (R2) | 15.51 | 14.98 | 15.54 | 15.88 | |
| Resistance 1 (R1) | 14.89 | 14.66 | 14.52 | 14.97 | 15.76 |
| Pivot Point | 14.14 | 14.14 | 13.95 | 14.17 | 14.14 |
| Support 1 (S1) | 13.52 | 13.61 | 13.15 | 13.60 | 12.80 |
| Support 2 (S2) | 12.77 | 13.29 | 12.80 | 12.68 | |
| Support 3 (S3) | 12.15 | 12.77 | 12.57 | ||
| Support 4 (S4) | 12.23 |
